Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 151 - 175 of 475
Concurrent DeepSight™ Comprehensive 523 genes Liquid Biopsy (Somatic) + Neovare Portfolio testing (Germline) Methodology Molecular Test Description Disease Solid tumors; Breast cancer, Ovarian cancer,
Concurrent DeepSight™ on Liquid + siPortfolio Multi-Omics™ on Tissue Methodology Molecular Test Description Disease Solid tumorsOn Tissue: siPortfolio Multi-Omics™ • NGS (500+ genes, TMB, MSI)
LymphoSight™ Test Description Probes/Genes IHC/CISH ALK1, BCL-1, BCL-2, BCL-6, BRAF, Bob1, CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD15, CD20, CD21, CD23, CD25*, CD30, CD43, CD79a, CD138, C-MYC, EBV-LMP, Granzyme B, ICOS*, IgA, IgG, IgG4, IgM, Kappa, Ki-67, Lambda, LEF1*, Mum1, OCT2, Pax5, Perforin, PD-1, TIA1. *: Pending CISH: EBER, Kappa,
ETV6 Heme single gene test Methodology Molecular Test Description Genes ETV6 Disease Myelodysplastic neoplasm, Leukemias (Acute myeloid leukemia (AML), Acute lymphoblastic leukemia (ALL), PDGFRB-associated
EZH2 Heme single gene test Methodology Molecular Test Description Genes EZH2 Disease Prostate cancer, breast cancer, Weaver Syndrome, colorectal cancer, endometrial cancer, lymphoma, and myelodysplastic
FBXW7 single gene test Methodology Molecular Test Description Genes FBXW7 (exons 6-9) Disease Colorectal adenocarcinoma, Ovarian serous cystadenoma breast cancer, leukemias, lung adenocarcinoma, skin
FGFR1 Heme single gene test Methodology Molecular Test Description Genes FGFR1 Disease Breast invasive ductal carcinoma, lung adenocarcinoma, colon adenocarcinoma, squamous cell lung carcinoma, stem cell
FGFR1 single gene test Methodology Molecular Test Description Genes FGFR1 Disease Breast invasive ductal carcinoma, lung adenocarcinoma, colon adenocarcinoma, squamous cell lung carcinoma, stem cell myeloproliferative
FGFR2 Heme single gene test Methodology Molecular Test Description Genes FGFR2 Disease Prostate cancer, cholangiocarcinoma, epidermal nevus, endometrial endometrioid adenocarcinoma, breast invasive ductal
FGFR2 single gene test Methodology Molecular Test Description Genes FGFR2 Disease Prostate cancer, cholangiocarcinoma, epidermal nevus, endometrial endometrioid adenocarcinoma, breast invasive ductal carcinoma,
FGFR3 single gene test Methodology Molecular Test Description Genes FGFR3 Disease Urothelial, breast, head and neck, lung, brain, gastric, pancreatic, colorectal, kidney, endometrial, ovarian, and cervical
FGFR4 single gene test Methodology Molecular Test Description Genes FGFR4 Disease Lung adenocarcinoma, colon adenocarcinoma, breast invasive ductal carcinoma, cutaneous melanoma, and endometrial endometrioid
FLT3 Mutation Analysis Alternative Name FLT3, FLT3 ITD Methodology Molecular Test Description Genes FLT3 (ITD variants , exon14,15) Disease Acute myeloid leukemia (AML), colon adenocarcinoma, lung adenocarcinoma,
FLT3 ITD/TKD Mutation Analysis Alternative Name FLT3, FLT3 TKD, FLT3 ITD Methodology Molecular Test Description Genes FLT3 ITD/TKD Disease Cytogenetically normal Acute Myeloid Leukemia & Acute Lymphoblastic
FUS single gene test Methodology Molecular Test Description Genes FUS Disease Endometrial cancer, intestinal cancer, skin cancer, melanoma, lung adenocarcinoma, colon adenocarcinoma, myxoid liposarcoma,
GATA2 single gene test Methodology Molecular Test Description Genes GATA2 Disease Acute myeloid leukemia, chronic myelomonocytic leukemia (CMML), myelodysplastic neoplasm & Non-Small Cell Lung Cancer
GNA11 single gene test Methodology Molecular Test Description Genes GNA11 Disease Uveal melanoma, lung adenocarcinoma, colon adenocarcinoma, breast invasive ductal carcinoma, and endometrial endometrioid
GNAQ single gene test Methodology Molecular Test Description Genes GNAQ Disease Uveal melanoma, lung adenocarcinoma, melanoma, endometrial endometrioid adenocarcinoma, and colon adenocarcinomaMolecular
HMGA2 single gene test Methodology Molecular Test Description Genes HMGA2 Disease Liver cancer, lung cancer, glioblastoma multiforme, dedifferentiated liposarcoma, breast invasive ductal carcinoma, glioma,
HRAS Heme single gene test Methodology Molecular Test Description Genes HRAS Disease Epidermal nevus, bladder urethelial carcinoma, follicular thyroid cancer, head and neck squamous cell carcinoma, kidney
HRAS single gene test Methodology Molecular Test Description Genes HRAS Disease Epidermal nevus, bladder urethelial carcinoma, follicular thyroid cancer, head and neck squamous cell carcinoma, kidney cancers,
IDH1 Heme Mutation Analysis Methodology Molecular Test Description Genes IDH1 common variants (eg, R132H, R132C) Disease Cytogenetically normal acute myeloid leukemia, Primary myelofibrosis, myelodysplastic
IDH1 Mutation Analysis Methodology Molecular Test Description Genes IDH1 common variants (eg, R132H, R132C) Disease Cytogenetically normal acute myeloid leukemia, Primary myelofibrosis, myelodysplastic
IDH2 Heme Mutation Analysis Methodology Molecular Test Description Genes IDH2 common variants (eg, R140W, R172M) Disease Cytogenetically normal acute myeloid leukemia, Primary myelofibrosis, myelodysplastic
IDH2 Mutation Analysis Methodology Molecular Test Description Genes IDH2 common variants (eg, R140W, R172M) Disease Cytogenetically normal acute myeloid leukemia, Primary myelofibrosis, myelodysplastic
IGH (B-Cell Gene rearrangement) Methodology Molecular Test Description Genes IGH Disease Diffuse large B-cell lymphoma, follicular lymphoma, mature B-cell neoplasm, chronic lymphocytic leukemia/small lymphocytic
IGHV single gene test Methodology Molecular Test Description Genes IGH variable region somatic mutation analysisIGHV mutational testing assesses the percentage of sequence variability between the V region
IKZF1 single gene test Methodology Molecular Test Description Genes IKZF1 Disease B-cell malignancies, Acute Lymphoblastic Leukemia (ALL), Immunodeficiency, Common Variable, 13 and Diamond-Blackfan Anemia-Like.Next
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.